Sign In
Samples
/
Brilinta
Cardiovascular
Brilinta
ticagrelor
Manufacturer
AstraZeneca
Indication
P2Y12 inhibitor for ACS, secondary prevention
Sample Info:
AZ&Me no longer accepting new patients as of April 2025.
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with AstraZeneca
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from AstraZeneca
View all
Farxiga
dapagliflozin
Diabetes
Tagrisso
osimertinib
Oncology
Lynparza
olaparib
Oncology
Imfinzi
durvalumab
Oncology
Fasenra
benralizumab
Respiratory
Breztri Aerosphere
budesonide/glycopyrrolate/formoterol
Respiratory
More Cardiovascular Samples
View all
Eliquis
apixaban
Pfizer
Xarelto
rivaroxaban
Janssen (J&J)
Entresto
sacubitril/valsartan
Novartis
Repatha
evolocumab
Amgen
Leqvio
inclisiran
Novartis
Pradaxa
dabigatran etexilate
Boehringer Ingelheim
Popular Samples
Browse all
Mounjaro
tirzepatide
Eli Lilly
Diabetes
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Zepbound
tirzepatide
Eli Lilly
Obesity
Keytruda
pembrolizumab
Merck
Oncology
Dupixent
dupilumab
Sanofi
Immunology
Jardiance
empagliflozin
Eli Lilly
Diabetes
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas